Yüklüyor......
Antipsychotic augmentation in the treatment of obsessive-compulsive disorder
Most studies suggest that obsessive-compulsive disorder runs a chronic course. Only 40%–70% of patients respond to first-line treatment with selective serotonin reuptake inhibitors (SSRIs). The most common pharmacological strategy used in clinical practice for partial responders to SSRIs is augmenta...
Kaydedildi:
| Yayımlandı: | Indian J Psychiatry |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Medknow Publications & Media Pvt Ltd
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6343405/ https://ncbi.nlm.nih.gov/pubmed/30745677 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/psychiatry.IndianJPsychiatry_519_18 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|